Cargando…
Comparison of the Protective Effects of Bee Venom Extracts with Varying PLA(2) Compositions in a Mouse Model of Parkinson’s Disease
Bee venom contains a number of pharmacologically active components, including enzymes and polypeptides such as phospholipase A(2) (PLA(2)) and melittin, which have been shown to exhibit therapeutic benefits, mainly via attenuation of inflammation, neurotoxicity, and nociception. The individual compo...
Autores principales: | Kim, Kyung Hwa, Kim, Minhwan, Lee, Jaehwan, Jeon, Hat Nim, Kim, Se Hyun, Bae, Hyunsu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628630/ https://www.ncbi.nlm.nih.gov/pubmed/31248167 http://dx.doi.org/10.3390/toxins11060358 |
Ejemplares similares
-
Comparison of Administration Routes on the Protective Effects of Bee Venom Phospholipase A2 in a Mouse Model of Parkinson’s Disease
por: Baek, Hyunjung, et al.
Publicado: (2018) -
Dose-Dependent Neuroprotective Effect of Standardized Bee Venom Phospholipase A(2) Against MPTP-Induced Parkinson’s Disease in Mice
por: Kim, Kyung Hwa, et al.
Publicado: (2019) -
Therapeutic Effects of Bee Venom on Immunological and Neurological Diseases
por: Hwang, Deok-Sang, et al.
Publicado: (2015) -
Evaluation of Phototoxic and Skin Sensitization Potentials of PLA(2)-Free Bee Venom
por: Heo, Yunwi, et al.
Publicado: (2015) -
Improved Therapeutic Profiles of PLA(2)-Free Bee Venom Prepared by Ultrafiltration Method
por: Lee, Hyunkyoung, et al.
Publicado: (2015)